We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0% → 68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
–
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
–
Reduced
–
Closed
–
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SIC
576
Schwartz Investment Counsel
Michigan
$2.56M +$2.7M +61,805 New
PAMG
577
Patton Albertson Miller Group
Tennessee
$2.54M +$2.69M +61,545 New
DCC
578
Dow Chemical Company
Michigan
$2.54M +$2.69M +61,500 New
HCMT
579
Highland Capital Management (Texas)
Texas
$2.54M +$2.68M +61,390 New
MA
580
Menlo Advisors
California
$2.54M +$2.69M +61,405 New
MA
581
Montag & Associates
Georgia
$2.51M +$2.66M +60,743 New
PSC
582
Prentiss Smith & Co
Vermont
$2.51M +$2.65M +60,676 New
Bessemer Group
583
Bessemer Group
New Jersey
$2.5M +$2.65M +60,619 New
RW
584
Rand Wealth
Maryland
$2.5M +$2.64M +60,395 New
CANC
585
Culbertson A N & Co
Virginia
$2.49M +$2.63M +60,231 New
WTB
586
Washington Trust Bank
Washington
$2.48M +$2.63M +60,077 New
Connor, Clark & Lunn Investment Management (CC&L)
587
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.48M +$2.49M +56,920 New
K
588
Kemper
Illinois
$2.48M +$2.62M +60,000 New
ACM
589
Aviance Capital Management
Florida
$2.47M +$2.62M +59,837 New
BCM
590
BTR Capital Management
California
$2.45M +$2.59M +59,175 New
HIC
591
Hartline Investment Corp
Illinois
$2.41M +$2.55M +58,369 New
DSC
592
Duncker Streett & Co
Missouri
$2.41M +$2.55M +58,196 New
KFA
593
Kelleher Financial Advisors
New York
$2.41M +$2.68M +61,200 New
CT
594
Cambridge Trust
Massachusetts
$2.4M +$2.53M +57,958 New
SBCM
595
Silver Bridge Capital Management
Massachusetts
$2.39M +$2.53M +57,842 New
AHS
596
Aspiriant Holdings S3
California
$2.38M +$2.51M +57,490 New
PP
597
Palladium Partners
Virginia
$2.38M +$2.52M +57,510 New
NCMW
598
Northern Capital Management (Wisconsin)
Wisconsin
$2.38M +$2.51M +57,465 New
NCMG
599
NCM Capital Management Group
North Carolina
$2.37M +$2.51M +57,400 New
BBA
600
BLB&B Advisors
Pennsylvania
$2.37M +$2.5M +57,203 New
22 23
24
25 26

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.